Biotech Values

[mskatiescarletohara]

Regarding Squalamine manufacturing...

Perhaps investors at the breakout session will raise this issue with Roy.

It's imperative for Squalamine to be manufactured on a consistent basis, in quality and quantity, GENR also needs secure manufacturing runs. GENR does not need to be dependent on a contract manufacturer who cannot provide the drug adequately when advancing into pivotals.

katie...